Medalist Diversified (MDRR) CEO purchases 40,000 shares at $15

Rhea-AI Filing Summary

Medalist Diversified, Inc. director and CEO Frank Kavanaugh reported an open-market-style purchase of common stock. On March 13, 2026, he bought 40,000 shares at $15.00 per share under a Stock Purchase Agreement with the Kramerica Trust Dated July 24, 2015. Following this transaction, he directly owns 646,177 shares of Medalist Diversified common stock.

Insider Trade Summary

Net Buyer: 40,000 shares

Net Buy 1 txn

Insider KAVANAUGH FRANK

Role CHAIRMAN, CEO & PRESIDENT

Bought 40,000 shs ($600K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	40,000	$15.00	$600K

Holdings After Transaction: Common Stock — 646,177 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a Stock Purchase Agreement dated March 13, 2026, Frank Kavanaugh purchased 40,000 shares of common stock for $15.00 per share from the Kramerica Trust Dated July 24, 2015.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/13/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What insider transaction did MDRR CEO Frank Kavanaugh report?

Frank Kavanaugh reported buying 40,000 shares of Medalist Diversified common stock. The shares were acquired on March 13, 2026 at $15.00 per share under a Stock Purchase Agreement with the Kramerica Trust Dated July 24, 2015.

At what price did Frank Kavanaugh purchase MDRR shares?

Frank Kavanaugh purchased Medalist Diversified (MDRR) common stock at $15.00 per share. The transaction covered 40,000 shares of common stock and was executed on March 13, 2026 pursuant to a Stock Purchase Agreement with the Kramerica Trust.

How many MDRR shares does Frank Kavanaugh hold after this transaction?

After the reported transaction, Frank Kavanaugh directly holds 646,177 shares of Medalist Diversified common stock. This total reflects his position immediately following the 40,000-share purchase completed on March 13, 2026 at a price of $15.00 per share.

Who sold the 40,000 MDRR shares to Frank Kavanaugh?

The Kramerica Trust Dated July 24, 2015 sold the shares to Frank Kavanaugh. Under a Stock Purchase Agreement dated March 13, 2026, Kavanaugh bought 40,000 shares of Medalist Diversified common stock for $15.00 per share from this trust.

What role does Frank Kavanaugh hold at Medalist Diversified (MDRR)?

Frank Kavanaugh serves as Chairman, CEO & President of Medalist Diversified, Inc. He is also reported as a director and ten percent owner in the filing that discloses his purchase of 40,000 shares of common stock at $15.00 per share.

Was the MDRR insider transaction an open-market purchase?

The transaction is categorized as an open-market purchase of common stock. However, the footnote clarifies that Frank Kavanaugh bought 40,000 shares at $15.00 each under a Stock Purchase Agreement with the Kramerica Trust Dated July 24, 2015.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KAVANAUGH FRANK

(Last) (First) (Middle)

MEDALIST DIVERSIFIED, INC.

POST OFFICE BOX 8436

(Street)

RICHMOND VA 23226

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medalist Diversified, Inc. [ MDRR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CHAIRMAN, CEO & PRESIDENT

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		P		40,000(1)	A	$15	646,177	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a Stock Purchase Agreement dated March 13, 2026, Frank Kavanaugh purchased 40,000 shares of common stock for $15.00 per share from the Kramerica Trust Dated July 24, 2015.

	/s/ Frank Kavanaugh	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.